Cargando…
Repurposing β-Lactams for the Treatment of Mycobacterium kansasii Infections: An In Vitro Study
Mycobacterium kansasii (Mkn) causes tuberculosis-like lung infection in both immunocompetent and immunocompromised patients. Current standard therapy against Mkn infection is lengthy and difficult to adhere to. Although β-lactams are the most important class of antibiotics, representing 65% of the g...
Autores principales: | Muñoz-Muñoz, Lara, Aínsa, José A., Ramón-García, Santiago |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952313/ https://www.ncbi.nlm.nih.gov/pubmed/36830246 http://dx.doi.org/10.3390/antibiotics12020335 |
Ejemplares similares
-
Therapy for Mycobacterium kansasii Infection: Beyond 2018
por: DeStefano, Michelle S., et al.
Publicado: (2018) -
Mycobacterium Kansasii Infection and Microscopic Polyangiitis: An Unexpected Association
por: Alnaser, Ammar, et al.
Publicado: (2018) -
Systemic Mycobacterium kansasii Infection in Two Related Cats
por: Černá, Petra, et al.
Publicado: (2020) -
Prosthetic Knee Joint Infection Caused by Mycobacterium kansasii
por: Dasari, Suhas P., et al.
Publicado: (2022) -
Mycobacterium kansasii Pulmonary Diseases in Korea
por: Yim, Jae-Joon, et al.
Publicado: (2005)